ViroVet's Series A Round

ViroVet raised a round of funding on January 19, 2017.

ViroVet is a biopharmaceutical company active in the development of vaccines and antiviral drugs for livestock. These vaccines are tailor-made to maximize efficacy and minimize safety concerns; in add…

Articles about ViroVet's Series A Round: